FindTrial
Sign In

A multicenter randomized controlled clinical study on surgical treatment of refractory vitiligo

A multicenter clinical study on surgical treatment of refractory vitiligo

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036712
Enrollment
Unknown
Registered
2020-08-24
Start date
2021-03-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo

Interventions

tissue-engineered skin transplantation: tissue-engineered skin transplantation
epidermal suction blister transplantation:epidermal suction blister transplantation
epidermal cell suspension transplantation:epidermal suction blister transplantation

Sponsors

Huashan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with vitiligo at a stable stage, defined as no new skin lesion within at least 1 year, no expansion of the original skin lesion, and no isomorphous reaction; 2. Aged between 18 and 65, no serious heart and lung diseases, no active infectious diseases, and no blood system diseases; 3. Other treatments are ineffective; 4. Sign the informed consent form and be willing to accept surgical treatment.

Exclusion criteria

Exclusion criteria: 1. Patients with scar constitution; 2. Patients who cannot cooperate with the operation; 3. Patients with serious medical or infectious diseases are not suitable for traumatic operation; 4. pregnancy; 5. Recently participated in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Area of extinction of white spot;—

Countries

China

Contacts

Public ContactJinhua Xu

Huashan Hospital Fudan University

xjhhsyy@163.com+86 13818978539

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026